Drugs, Diagnostics and Delivery

from Personalised Medicine to Global Health

Wed 15 Sept 2010 at the Birmingham Conservatoire

Presentations Participants Speaker profiles

Speakers

Philip JohnsonCancer Treatment, Diagnosis and Clinical Trials
Professor Philip Johnson, Director of the Cancer Research UK Clinical Trials Unit, University of Birmingham, which runs up to forty trials at any one time, encompassing all stages of drug development from 'first use' studies to large randomized trials involving up to ten thousand patients.

John DarlingThe Brain Tumour Research Centre
Professor John Darling, Dean of the School of Applied Sciences and Director of the Research Institute in Healthcare Science, University of Wolverhampton, is focusing on the development and testing of novel therapeutics for malignant brain tumours.

Subhasis BanarjeeBiomarkers: from R&D to clinical studies
Dr Subhasis Banarjee, Director of Origin Biomarkers and based at Heartlands Hospital, won support from Advantage West Midlands to commercialise new immunodiagnostic assays for pregnancy disorders, and is developing biological markers for cancer and inflammatory disorders.

Monica SpiteriMeeting clinical needs through innovative technologies
Professor Monica Spiteri, Director of Lung Research at the University Hospital of North Staffordshire and Keele University, is developing near patient technologies for Chronic Obstructive Airways Disease with support from the National Institute of Health Research and NHS West Midlands Innovations.

Alan DaviesFuture Directions in Healthcare
Dr Alan Davies, Chief Medical Officer at GE Healthcare, presents on the convergence of biology, imaging, and information technology, revealing how large scale change can be implemented for the treatment of cancer, stroke and rheumatoid arthritis.

Format

Professor John Darling, Dean of the School of Applied Sciences and Director of the Research Institute in Healthcare Science, University of Wolverhampton, is focussing on the development and testing of novel therapeutics for malignant brain tumours.

Tickets

Tickets are available at sciencecapital.eventbrite.com

Use "earlybird" for 10% discount until 1 Sept or sold out.

This event is a Fringe Event for the British Science Festival.

Please sign up to our mailing list to receive further information.

Sponsors

Birmingham City Council

The Binding SiteMedilink

Bluebeerry Consultants

Designated charity

Cure Leukaemia